| Bacteriology, safety and prevention of infection associated with continuous intravenous infusions. | |
| | |
MedLine Citation:
|
PMID: 8735797 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There are over 50,000 intravascular catheter-associated bloodstream infections in the United States each year; globally, the number of these infections is likely to be much higher. At least half of these bloodstream infections are caused by staphylococci. The source of most pathogens causing endemic catheter-associated bloodstream infections is the catheter insertion site or the catheter hub, whereby microbes migrate into the bloodstream along the outside or inside of the catheter, respectively. The pathogenesis of epidemic intravascular catheter-related bloodstream infections is quite different. Epidemic bloodstream infections are due to manufacturer-related contamination or contamination that occurs at the location of catheter use, such as the hospital. These epidemics have most often been traced to contamination of intravenous solutions such as hyperalimentation or medications, blood products, contaminated cutaneous antiseptics or faulty decontamination of reusable devices. The prevention of infection associated with continuous intravenous infusion of factor VIII poses a number of challenges. Assurances of the sterility of the product is of paramount importance, as is proper storage of the product prior to use. Prevention of infection will further require particular attention to the conditions surrounding insertion of the catheter, including the optimal site of insertion, maximal barrier precautions and optimal disinfection of the insertion sites, and also to conditions surrounding maintenance of the device after insertion, including proper disinfection and aseptic techniques when manipulating the catheter hub, daily assessment of the insertion site, and maintaining scheduled changes of the intravenous tubing. With proper precautions, the risk of serious infection associated with a continuous infusion of factor VIII should be minimal. |
| | |
Authors:
|
L A Mermel |
Related Documents
:
|
17762237 - Diagnosis and prevention of catheter-related infections. 16449537 - Successful clearance of catheter-related bloodstream infection by antibiotic lock thera... 12006957 - A national point-prevalence survey of pediatric intensive care unit-acquired infections... 8221857 - Catheter lavage and drainage of pneumococcal pericarditis. 16262027 - Entamoeba moshkovskii and entamoeba dispar-associated infections in pondicherry, india. 17762237 - Diagnosis and prevention of catheter-related infections. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Volume: 7 Suppl 1 ISSN: 0957-5235 ISO Abbreviation: Blood Coagul. Fibrinolysis Publication Date: 1996 Mar |
Date Detail:
|
Created Date: 1996-10-10 Completed Date: 1996-10-10 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9102551 Medline TA: Blood Coagul Fibrinolysis Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: S45-51 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Rhode Island Hospital Providence, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bacteremia
/
etiology*,
prevention & control* Catheterization, Central Venous / adverse effects* Humans |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Central venous access catheters in children with haemophilia.
Next Document: Effects of poloxamer 407 on the assembly, structure and dissolution of fibrin clots.